Elevar Therapeutics and Neopharma establish a JV for the Commercialization of Rivoceranib in MENA and India
October 3, 2019 SALT LAKE CITY, USA. Elevar Therapeutics and Abu Dhabi-based Neopharma have entered into an agreement to establish a joint venture in the United Arab Emirates. The 50:50 venture is planned to undertake a broad range of development and commercialization activities for